Abstract
To examine the appropriate treatment of oligo-terato-asthenozoospermic patients with metabolic syndrome, 45 patients were treated with metformin for 6 months. The use of metformin was associated with a statistically significant reduction in insulin resistance and sex hormone-binding globulin levels, a statistically significant increase in serum androgen levels, and a consequent improvement in semen characteristics.
Original language | English |
---|---|
Pages (from-to) | 2150-2152 |
Number of pages | 3 |
Journal | Fertility and Sterility |
Volume | 95 |
Issue number | 6 |
DOIs | |
State | Published - 1 May 2011 |
Keywords
- Metabolic syndrome
- metformin
- OTA
- semen
- testosterone
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology